HHBT.US HH Biotechnology Holdings Company

Real Estate Real Estate Management & Development USA Stocks
0.0001 USD
Close of Oct 14, 2026
0.0001 0.0001
Market cap
USD 1.41K
P/E
-
P/B
0.26x
ROE
8.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2016.

Is HHBT.US undervalued?

Graham number

The Graham number of HH Biotechnology Holdings Company cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

HH Biotechnology Holdings Company fundamental analysis

No fundamental analysis for HH Biotechnology Holdings Company yet.

HH Biotechnology Holdings Company stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About HH Biotechnology Holdings Company

HH Biotechnology Holdings Company engages in health and green industries. It focuses on planting and supplying macadamia nuts for use in foods, cooking oils, healthy products, toiletries, and cosmetics. The company was formerly known as Great China International Holdings, Inc. and changed its name to HH Biotechnology Holdings Company in August 2016. HH Biotechnology Holdings Company was incorporated in 1987 and is headquartered in Shenyang, the People's Republic of China.

Full company profile